Results 101 to 110 of about 17,525 (157)

Case Report: Should IGF-1R targeted therapy be revisited in Ewing sarcoma? a report of long-term complete response and review of the literature. [PDF]

open access: yesFront Oncol
Stergiopoulos GM   +7 more
europepmc   +1 more source

AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R. [PDF]

open access: yesMolecules, 2022
Li K   +7 more
europepmc   +1 more source

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease. [PDF]

open access: yesFront Endocrinol (Lausanne), 2023
Gulbins A   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy